Concordance analysis of two databases to search for potential drug interactions in onco-hematologic patients
- 30 January 2024
- journal article
- research article
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 31 (1) , 90-97
Abstract
Introduction: Potential drug interactions exert a significant impact on patient safety, especially within intricate onco-hematological treatments, potentially resulting in toxicity or treatment failures. Despite the availability of databases for potential drug interaction investigation, persistent heterogeneity in concordance rates and classifications exists. The additional variability in database agreement poses further complexity, notably in critical contexts like onco-hematology. Aim: To analyze the concordance of two databases for researching potential drug interaction in prescriptions for hematological patients at a University Hospital in the Midwest region of Brazil. Method: Cross-sectional study developed in a Brazilian hospital. The search for potential drug interaction was conducted in Micromedex® and UpToDate®. The variables were: the presence of potential drug interaction, severity, mechanism, management, and documentation. Data was analyzed in terms of frequency (absolute and relative), Cohen's kappa, and Fleiss kappa . Results: The presence of potential drug interaction, showed a lack of concordance between the databases ( k = −0.115 [95% CI: 0.361–0.532], p = 0.003). Regarding the mechanism, a strong agreement was observed ( k = 0.805, p < 0.001 [95% CI: 0.550–0.941]). The management concordance showed a fair agreement, 46.8% ( k = 0.22, p < 0.001 [95% CI: 0.099–0.341]). Stratifying the categories, significant concordance was observed in “Adjustment of dose + Monitoring” ( k = 0.302, p = 0.018) and “Monitoring” ( k = 0.417, p = 0.001), while other categories did not reach statistical significance. Conclusion: Our study emphasizes the variability in potential drug interaction research, revealing disparities in severity classification, management recommendations, and documentation practices across databases.Keywords
This publication has 23 references indexed in Scilit:
- Potential drug–drug interactions in hospitalised haematological patientsJournal of Oncology Pharmacy Practice, 2016
- Assessment of potential drug–drug interactions and its associated factors in the hospitalized cardiac patientsSaudi Pharmaceutical Journal, 2016
- Potential drug–drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factorsInternational Journal of Clinical Pharmacy, 2015
- Drug interaction databases in medical literature: transparency of ownership, funding, classification algorithms, level of documentation, and staff qualifications. A systematic reviewEuropean Journal of Clinical Pharmacology, 2015
- Prevalence and clinical significance of potential drug–drug interaction in hematopoietic stem cell transplantationCancer Chemotherapy and Pharmacology, 2014
- Drug-drug interaction software in clinical practice: a systematic reviewEuropean Journal of Clinical Pharmacology, 2014
- Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugsBritish Journal of Cancer, 2013
- Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposedJournal of Clinical Epidemiology, 2011
- Drug-Drug Interactions Associated with Length of Stay and Cost of HospitalizationJournal of Pharmacy & Pharmaceutical Sciences, 2009
- The Measurement of Observer Agreement for Categorical DataBiometrics, 1977